Proresolving protein Annexin A1: The role in type 2 diabetes mellitus and obesity

Nathalia T. Pietrani, Cláudia N. Ferreira, Kathryna F. Rodrigues, Luiza O. Perucci, Fernanda S. Carneiro, Adriana A. Bosco, Marina C. Oliveira, Solange S. Pereira, Antônio L. Teixeira, Jacqueline I. Alvarez-Leite, Adaliene V. Ferreira, Lirlândia P. Sousa, Karina B. Gomes

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Background: Annexin A1 (AnxA1) is a protein involved in inflammation resolution that might be altered in obesity-associated type 2 diabetes mellitus (DM), which is a chronic inflammatory disease. The aim of this study was to evaluate AnxA1 serum levels in individuals with and without DM stratified according to the body mass index (BMI), and the dynamic of AnxA1 expression in adipose tissue from humans with obesity and non-obesity. Methods: Serum samples were obtained from 41 patients with DM (lean, overweight and obese) and 40 controls, and adipose tissue samples were obtained from 16 individuals with obesity (with or without DM), and 15 controls. Results: DM patients showed similar AnxA1 serum levels when compared to controls. However, when the individuals were stratified according to BMI, AnxA1 levels were higher in individuals with obesity than lean or overweight, and in overweight compared to lean individuals. Moreover, AnxA1 was correlated positively with IL-6 levels. AnxA1 levels were also positively correlated with BMI, waist circumference and waist-to-hip ratio. Furthermore, higher levels of cleaved AnxA1 were observed in adipose tissue from individuals with obesity, independently of DM status. Conclusions: Enhanced levels of AnxA1 in serum of individuals with obesity suggest an attempt to counter-regulate the systemic inflammation process in this disease. However, the higher levels of cleaved AnxA1 in the adipose tissue of individuals with obesity could compromise its anti-inflammatory and proresolving actions, locally. Considering our data, AnxA1 cleavage in the adipose tissue, despite increased serum levels of this protein, and consequently the failure in inflammation resolution, suggests an important pathophysiological mechanism involved in inflammatory status observed in obesity.

Original languageEnglish (US)
Pages (from-to)482-489
Number of pages8
JournalBiomedicine and Pharmacotherapy
StatePublished - Jul 2018
Externally publishedYes


  • Annexin A1
  • Inflammation resolution
  • Obesity
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Proresolving protein Annexin A1: The role in type 2 diabetes mellitus and obesity'. Together they form a unique fingerprint.

Cite this